Refocusing Peroxisome Proliferator Activated Receptor-α: A New Insight for Therapeutic Roles in Diabetes

Refocusing Peroxisome Proliferator Activated Receptor-α: A New Insight for Therapeutic Roles in Diabetes

Although glucose-lowering treatment shows some risk lowering effects in cardiovascular diseases, risks of macrovascular and microvascular complications have still remained, and development of new therapeutic strategies is needed. Recent data have shown that peroxisome proliferator activated receptor...

Full description

Bibliographic Details
Main Authors:	Hannah Seok, Bong Soo Cha
Format:	Article
Language:	English
Published:	Korean Diabetes Association 2013-10-01
Series:	Diabetes & Metabolism Journal
Subjects:	Diabetes Diabetes complications Fibric acids Peroxisome proliferator activated receptor agonists
Online Access:	http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-37-326.pdf

Similar Items

The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases
by: Sandeep Tyagi, et al.
Published: (2011-01-01)

Peroxisome Proliferator-Activated Receptor α Agonist and Its Target Nanog Cooperate to Induce Pluripotency
by: Jungwoon Lee, et al.
Published: (2018-11-01)

Role of peroxisome proliferator-activated receptors in diabetic vascular dysfunction.
Published: (2011)

Effects of Sulfonylureas on Peroxisome Proliferator-Activated Receptor γ Activity and on Glucose Uptake by Thiazolidinediones
by: Kyeong Won Lee, et al.
Published: (2011-08-01)

The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease
by: Sun Xin, et al.
Published: (2017-03-01)

Downregulation of peroxisome proliferator‐activated receptor gamma in the placenta correlates to hyperglycemia in offspring at young adulthood after exposure to gestational diabetes mellitus
by: Qihong Zhao, et al.
Published: (2019-03-01)

Fenofibrate, but not ezetimibe, prevents fatty liver disease in mice lacking phosphatidylethanolamine N-methyltransferase
by: Jelske N. van der Veen, et al.
Published: (2017-04-01)

Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR)
by: Fisman Enrique Z, et al.
Published: (2003-03-01)

An innovative approach for the treatment of Alzheimer’s disease: the role of peroxisome proliferator-activated receptors and their ligands in development of alternative therapeutic interventions
by: Luca Piemontese
Published: (2019-01-01)

Oleamide activates peroxisome proliferator-activated receptor gamma (PPARγ) <it>in vitro</it>
by: Dionisi Mauro, et al.
Published: (2012-05-01)

The Relationship of the Peroxisome Proliferator Activated ReceptorGamma 2 Exon 2 and Exon 6 Gene Polymorphism in Type 2 Diabetic Patients with and without Diabetic Foot Ulcers
by: Mehmet Erdogan, et al.
Published: (2014-12-01)

Structural Biology-Based Exploration of Subtype-Selective Agonists for Peroxisome Proliferator-Activated Receptors
by: Hiroyuki Miyachi
Published: (2021-08-01)

Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia
by: Yuina Wada, et al.
Published: (2020-12-01)

OXPHOS deficiencies affect peroxisome proliferation by downregulating genes controlled by the SNF1 signaling pathway
by: Carolino, K., et al.
Published: (2022)

Linalool is a PPARα ligand that reduces plasma TG levels and rewires the hepatic transcriptome and plasma metabolome[S]
by: Hee-jin Jun, et al.
Published: (2014-06-01)

Screening for PPAR Non-Agonist Ligands Followed by Characterization of a Hit, AM-879, with Additional No-Adipogenic and cdk5-Mediated Phosphorylation Inhibition Properties
by: Helder Veras Ribeiro Filho, et al.
Published: (2018-02-01)

Studies on the identification and function of metabolites involved in peroxisome proliferator-activated receptor (PPAR) α activation
by: Takahashi, Haruya
Published: (2014)

Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease
by: Anne Fougerat, et al.
Published: (2020-07-01)

Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Trophoblast Functions
by: Lin Peng, et al.
Published: (2021-01-01)

The Effect of Peroxisome Proliferator-Activated Receptors (PPARs) in Male Fertility
by: Motahareh Sadat Mousavi, et al.
Published: (2020-09-01)

THE ADIPOCYTE AND ENDOTHELIAL CELL-SPECIFIC ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA IN BREAST TUMOURIGENESIS
by: Reid, ALEXIS
Published: (2012)

Investigation of peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and its effect on peroxisome proliferator-activated receptor-gamma mRNA expression in human cancer cell lines
by: Hatice Kurnaz, et al.
Published: (2019-12-01)

Peroxisome proliferator-activated receptor δ rescues xCT-deficient cells from ferroptosis by targeting peroxisomes
by: Jung Seok Hwang, et al.
Published: (2021-11-01)

Peroxisome proliferator-activated receptor-α accelerates α-chlorofatty acid catabolism
by: ElisaN.D. Palladino, et al.
Published: (2017-02-01)

Treatment with a New Peroxisome Proliferator-Activated Receptor Gamma Agonist, Pyridinecarboxylic Acid Derivative, Increases Angiogenesis and Reduces Inflammatory Mediators in the Heart of Trypanosoma cruzi-Infected Mice
by: Federico Nicolás Penas, et al.
Published: (2017-12-01)

Functional Activation of Peroxisome Proliferator-Activated Receptor α (PPARα) by Environmental Chemicals in Relation to Their Toxicities
by: AOYAMA, TOSHIFUMI, et al.
Published: (2002)

Peroxisome proliferator-activated receptor gamma as modulator of inflammation in pulmonary sarcoidosis
by: Pejčić Tatjana, et al.
Published: (2013-01-01)

Peroxisome proliferator-activated receptors-γ and hypertension: Lessons of the history of researches
by: M S Rasin
Published: (2013-09-01)

A comparison of peroxisome proliferator-activated receptor-α agonist and antagonist on human umbilical vein endothelial cells angiogenesis
by: Nasim Dana, et al.
Published: (2013-01-01)

An aPPARent Functional Consequence in Skeletal Muscle Physiology via Peroxisome Proliferator-Activated Receptors
by: Wendy Wen Ting Phua, et al.
Published: (2018-05-01)

Astaxanthin as a Peroxisome Proliferator-Activated Receptor (PPAR) Modulator: Its Therapeutic Implications
by: Chang-Ik Choi
Published: (2019-04-01)

Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol induced steatohepatitis in mice
by: Kong Lingbo, et al.
Published: (2011-12-01)

Role of GW0742 A PPARβ/δ Agonist on Coronary Angiogenesis in Control and Diabetic Rats
by: Ensieh Salehi, et al.
Published: (2011-08-01)

AZ 242, a novel PPARα/γ agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats
by: Bengt Ljung, et al.
Published: (2002-11-01)

Expression of peroxisome proliferator-activated receptor γ in rat retina during development
by: Ju-Ming Zhu, et al.
Published: (2015-02-01)

PD‐1 expression affects cytokine production by ILC2 and is influenced by peroxisome proliferator‐activated receptor‐γ
by: Banu Batyrova, et al.
Published: (2020-03-01)

Molecular Characterization and Expression Analysis of the Peroxisome Proliferator Activated Receptor Delta () Gene before and after Exercise in Horse
by: Hyun-Woo Cho, et al.
Published: (2015-05-01)

Crosstalk between Peroxisome Proliferator-Activated Receptors andToll-Like Receptors: A Systematic Review
by: Nasim Dana, et al.
Published: (2019-02-01)

High concentrations of phenylalanine stimulate peroxisome proliferator-activated receptor γ: Implications for the pathophysiology of phenylketonuria
by: Udo Schumacher, et al.
Published: (2008-12-01)

Effect of aerobic-resistance training on plasma level of Peroxisome proliferator 1α in patients after coronary artery bypass grafting: A clinical trial study
by: Azar Hamidi, et al.
Published: (2021-07-01)